Revvity, Inc. (NYSE:RVTY) Stock Holdings Raised by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co grew its stake in Revvity, Inc. (NYSE:RVTY) by 18.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,019 shares of the company’s stock after purchasing an additional 2,059 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Revvity were worth $1,453,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. EdgePoint Investment Group Inc. increased its stake in Revvity by 34.6% during the third quarter. EdgePoint Investment Group Inc. now owns 2,685,775 shares of the company’s stock valued at $343,108,000 after purchasing an additional 690,534 shares during the last quarter. Southpoint Capital Advisors LP bought a new stake in shares of Revvity during the 3rd quarter valued at about $25,550,000. Proficio Capital Partners LLC raised its stake in Revvity by 12,298.3% during the fourth quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company’s stock worth $21,850,000 after acquiring an additional 194,190 shares during the period. Vanguard Group Inc. lifted its holdings in Revvity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company’s stock worth $1,594,930,000 after acquiring an additional 156,679 shares during the last quarter. Finally, Tocqueville Asset Management L.P. lifted its holdings in Revvity by 91.2% in the fourth quarter. Tocqueville Asset Management L.P. now owns 234,625 shares of the company’s stock worth $26,186,000 after acquiring an additional 111,937 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

Insider Activity at Revvity

In other news, insider Tajinder S. Vohra sold 5,492 shares of the business’s stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the sale, the insider now directly owns 19,652 shares in the company, valued at $2,295,550.12. The trade was a 21.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Joel S. Goldberg sold 15,170 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the sale, the insider now owns 33,400 shares in the company, valued at $4,232,782. The trade was a 31.23 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.68% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Raymond James restated an “outperform” rating and issued a $145.00 price target (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price on the stock in a research note on Friday, December 13th. Sanford C. Bernstein cut Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target for the company. in a research note on Friday, January 10th. KeyCorp lifted their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Finally, Barclays increased their target price on shares of Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Revvity presently has a consensus rating of “Moderate Buy” and a consensus price target of $136.25.

Revvity Price Performance

NYSE:RVTY opened at $105.65 on Friday. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The firm has a market cap of $12.69 billion, a PE ratio of 47.81, a price-to-earnings-growth ratio of 3.82 and a beta of 1.06. Revvity, Inc. has a 12 month low of $97.32 and a 12 month high of $129.50. The company’s 50-day moving average price is $115.16 and its two-hundred day moving average price is $117.16.

Revvity (NYSE:RVTY) last announced its earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period last year, the firm earned $1.25 earnings per share. On average, equities analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.27%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s payout ratio is 12.67%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.